| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |